Mike Khouw joins 'Fast Money' to talk the options trade around Hims. Federal judge blocks largest supermarket merger in ...

Todd Gordon, founder of Inside Edge Capital, joins CNBC's 'Power Lunch' to discuss why he's keeping an eye on shares of these ...

Hims & Hers Health is financially strong with minimal debt and a dominant market share. Find out what makes HIMS stock a ...

Hims & Hers can beat Amazon in the telehealth market thanks to its unique advantages. Find out why HIMS stock is a Buy.

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $32.21 which represents a slight increase of $1.36 or 4.41% from the prior close of $30.85. The stock opened at $31.29 and ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

Investors in Hims & Hers Health Inc (Symbol: HIMS) saw new options begin trading today, for the January 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

The digital health industry has experienced impressive growth, driven by rising healthcare demands, digitalization, and ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

Analyst Maria Ripps of Canaccord Genuity maintained a Buy rating on Hims & Hers Health (HIMS – Research Report), retaining the price target of $38.00. Don't Miss our Black Friday Offers: Unlock your ...

Canaccord raised the firm’s price target on Hims & Hers to $38 from $28 and keeps a Buy rating on the shares. The stock rallied 70% in ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is proud to announce its ...